Brexit Highlights Strong British Presence In EU Medicines Network
This article was originally published in SRA
Executive Summary
The decision by the UK to leave the EU has highlighted the important role the Medicines and Healthcare products Regulatory Agency plays in the European pharmaceutical regulatory network.